Latest News (EN)
RASolute 302 Study Shows Daraxonrasib Increases Survival in Metastatic Pancreatic Cancer
Resultados finals from the RASoute 302 study were presented at the American Society of Clinical Oncology plenary session. Daraxonrasib, an oral tablet,...
